Atıf Formatları
Exenatide improves cardiovascular risk factors in obese patients with type 2 diabetes mellitus: a prospective study
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

D. Koseoglu Et Al. , "Exenatide improves cardiovascular risk factors in obese patients with type 2 diabetes mellitus: a prospective study," TURKISH JOURNAL OF MEDICAL SCIENCES , vol.51, no.1, pp.167-174, 2021

Koseoglu, D. Et Al. 2021. Exenatide improves cardiovascular risk factors in obese patients with type 2 diabetes mellitus: a prospective study. TURKISH JOURNAL OF MEDICAL SCIENCES , vol.51, no.1 , 167-174.

Koseoglu, D., Koparal, S. S., Baser, Ö., & Berker, D., (2021). Exenatide improves cardiovascular risk factors in obese patients with type 2 diabetes mellitus: a prospective study. TURKISH JOURNAL OF MEDICAL SCIENCES , vol.51, no.1, 167-174.

Koseoglu, Derya Et Al. "Exenatide improves cardiovascular risk factors in obese patients with type 2 diabetes mellitus: a prospective study," TURKISH JOURNAL OF MEDICAL SCIENCES , vol.51, no.1, 167-174, 2021

Koseoglu, Derya Et Al. "Exenatide improves cardiovascular risk factors in obese patients with type 2 diabetes mellitus: a prospective study." TURKISH JOURNAL OF MEDICAL SCIENCES , vol.51, no.1, pp.167-174, 2021

Koseoglu, D. Et Al. (2021) . "Exenatide improves cardiovascular risk factors in obese patients with type 2 diabetes mellitus: a prospective study." TURKISH JOURNAL OF MEDICAL SCIENCES , vol.51, no.1, pp.167-174.

@article{article, author={Derya Koseoglu Et Al. }, title={Exenatide improves cardiovascular risk factors in obese patients with type 2 diabetes mellitus: a prospective study}, journal={TURKISH JOURNAL OF MEDICAL SCIENCES}, year=2021, pages={167-174} }